ACTG Stock Recent News Acacia Research Corp (ACTG) 18.67 11/14/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Acacia Research Corp (ACTG) 18.67 $ACTG

Update: Marathon Patent Group Reports Outstanding Q3 Revenues And Earnings
Mobile Guru - at Seeking Alpha - Thu Nov 13, 6:20AM CST

ACTG: 18.67 (-0.08), MARA: 14.60 (-0.26)

Acacia's subsidiary and Gutierrez-Palmenberg enter into a royalty-bearing patent license agreement
M2 - Thu Nov 13, 4:30AM CST
Patent licensing company Acacia Research Corporation (Nasdaq:ACTG) announced on Wednesday that its subsidiary, Brandywine Communications Technologies LLC, has entered into a a royalty-bearing patent license agreement with Gutierrez-Palmenberg Inc dba Phoenix Internet.
ACTG: 18.67 (-0.08)

Acacia's subsidiary and IBM enter into a settlement and patent license agreement
M2 - Thu Nov 13, 4:25AM CST
Patent licensing company Acacia Research Corporation (Nasdaq:ACTG) announced on Wednesday that its subsidiary, Database Sync Solutions LLC, has entered into a settlement and patent license agreement with International Business Machines Corporation (IBM)(NYSE:IBM).
IBM: 164.16 (+1.37), ACTG: 18.67 (-0.08)

Acacia Subsidiary Enters into Settlement and Patent License Agreement with IBM
Business Wire - Wed Nov 12, 5:00AM CST
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Database Sync Solutions LLC subsidiary has entered into a settlement and patent license agreement with International Business Machines Corporation. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
ACTG: 18.67 (-0.08), IBM: 164.16 (+1.37)

Acacia Subsidiary Enters into a Royalty-Bearing Patent License Agreement with Gutierrez-Palmenberg, Inc. dba Phoenix Internet
Business Wire - Wed Nov 12, 4:59AM CST
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary entered into a royalty-bearing patent license agreement with Gutierrez-Palmenberg, Inc. dba Phoenix Internet.
ACTG: 18.67 (-0.08)

Acacia's subsidiary signs settlement and patent license agreement with Huawei Technologies
M2 - Tue Nov 11, 4:10AM CST
Patent licensing company Acacia Research Corporation (Nasdaq:ACTG) announced on Monday that ADAPTIX Inc, its subsidiary, has entered into a settlement and patent license agreement with Huawei Technologies Co Ltd.
ACTG: 18.67 (-0.08)

Acacia Subsidiary Enters into Settlement and Patent License Agreement with Huawei Technologies Co., Ltd.
Business Wire - Mon Nov 10, 5:00AM CST
Acacia Research Corporation (NASDAQ:ACTG) announced today that its ADAPTIX, Inc. subsidiary entered into a settlement and patent license agreement with Huawei Technologies Co., Ltd. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas and litigation that was pending in Tokyo District Court asserting patent infringement by certain Huawei Equipment.
ACTG: 18.67 (-0.08)

Acacia Subsidiary Enters into Settlement and Patent License Agreement with MegaPath Corporation
Business Wire - Fri Oct 31, 12:34PM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary entered into a settlement and patent license agreement with MegaPath Corporation. The agreement resolved litigation that was pending in the United States District Court for the District of Delaware.
ACTG: 18.67 (-0.08)

Acacia Research Corporation to Host Analyst and Investor Day
Business Wire - Tue Oct 28, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that it will host an analyst and investor day Wednesday, November 5, 2014. The event will be held at The New York Palace Hotel in New York City. Presentations by key members of Acacia's management team will be featured and will begin at 9:00 AM EST.
ACTG: 18.67 (-0.08)

Update: Acacia Research's Third Quarter Earnings
Rochelle Jenks - at Seeking Alpha - Fri Oct 24, 6:33AM CDT

ACTG: 18.67 (-0.08)

Update: Acacia Research Q3 Earnings - Revenue Expected To Rise On A Very Strong Pipeline Of Trials
Martin Vlcek - at Seeking Alpha - Fri Oct 24, 6:02AM CDT

ACTG: 18.67 (-0.08)

Acacia Research's (ACTG) CEO Matthew Vella on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 22, 8:57PM CDT

ACTG: 18.67 (-0.08)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:39PM CDT

TSCO: 74.86 (+0.91), AIRM: 44.22 (+0.23), VAR: 87.58 (-1.10), CAKE: 47.40 (-0.50), ACTG: 18.67 (-0.08), SCSS: 26.53 (-0.13), ADHD: 3.66 (+0.06), VII: 1.65 (+0.04), YELP: 59.82 (+1.72), HLSS: 18.92 (-0.24)

Acacia Research reports 3Q loss
Automated Insights - Wed Oct 22, 4:28PM CDT
NEWPORT BEACH, Calif. (AP) _ Acacia Research Corp. (ACTG) on Wednesday reported a third-quarter loss of $12.4 million.
ACTG: 18.67 (-0.08)

Acacia Research declares $0.125 dividend
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:03PM CDT

ACTG: 18.67 (-0.08)

Acacia Research beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 3:05PM CDT

ACTG: 18.67 (-0.08)

Acacia Research Reports Third Quarter Financial Results and Announces Payment of Quarterly Dividend
Business Wire - Wed Oct 22, 3:00PM CDT
Acacia Research Corporation(1) (Nasdaq: ACTG) today reported results for the three months ended September 30, 2014.
ACTG: 18.67 (-0.08)

Acacia Research (ACTG) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 22, 12:25PM CDT

ACTG: 18.67 (-0.08)

Acacia Subsidiary Enters into an Agreement with Blackberry Corporation and Blackberry Limited
Business Wire - Mon Oct 20, 5:00AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Cell and Network Selection LLC subsidiary entered into an agreement with Blackberry Corporation and Blackberry Limited. The agreement resolved litigation that was pending between Cell and Network Selection LLC and Blackberry in the United States District Court for the Eastern District of Texas.
ACTG: 18.67 (-0.08)

Acacia Subsidiary Enters into Settlement and Patent License Agreement with the Vanguard Group, Inc. and Vanguard Marketing Corporation
Business Wire - Mon Oct 20, 4:59AM CDT
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Unified Messaging Solutions LLC subsidiary has entered into a settlement and patent license agreement with The Vanguard Group, Inc. and Vanguard Marketing Corporation. The agreement resolves litigation that was pending in the United States District Court for the Southern District of New York.
ACTG: 18.67 (-0.08)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 6

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

A Closer Look at Marvell Tech's Upcoming Earnings Release

Updated Category News Views 184

Marvell Tech's Expected Earnings Release Marvell Tech (NASDAQ: MRVL) is set to announce its latest quarterly earnings in December. As investors await this critical financial moment, a brief review of what to expect can shed light on potential impacts and opportunities. Analysts' Earnings Projections Analysts forecast that Marvell Tech will achieve an earnings per share...

Continue Reading
Banijay Group's Recent Share Transactions Update and Insights

Updated Category News Views 222

Recent Share Transactions Overview Banijay Group N.V. (ISIN: NL0015000X07, Bloomberg: BNJ NA, Reuters: BNJ.AS) has reported on its recent share transactions, showcasing the buying and selling activities from the period of September 22 to September 26. Understanding Share Transactions During this timeframe, a mix of buying and selling occurred within the company’s...

Continue Reading
Strategic Growth for Voyageur Mineral Explorers via New Offering

Updated Category News Views 143

Voyageur Mineral Explorers Corp. Secures Massive Funding Voyageur Mineral Explorers Corp. (CSE: VOY) has recently made headlines by completing a significant brokered offering, raising $37.5 million. This financial boost comes at a crucial time for the Company as it seeks to expand its operations and investments in the mineral exploration sector. The offering was executed...

Continue Reading
Applied Materials Faces Challenges Amid Weak Outlook and Stocks

Updated Category News Views 114

Applied Materials Inc. Stock Performance Applied Materials Inc. (NASDAQ: AMAT) recently experienced a noticeable decline in its stock value as the company shared its financial results. After the market closure, the organization revealed its third-quarter earnings, leading to significant concern among investors. The stock's value tumbled, reflecting the market's reaction...

Continue Reading
VFC Class Action Demands Attention: Key Details for Investors

Updated Category News Views 192

Understanding the VFC Class Action Lawsuit Investors in V.F. Corporation, commonly known as VFC, should pay close attention to a pending class action lawsuit that could have significant implications. The law firm Faruqi & Faruqi, a reputable name in securities litigation, has stepped forward to represent affected investors. They are drawing attention to a critical...

Continue Reading